Patient: Page 2


  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia

    With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.

    By May 9, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Pharma's solution to the digital advertising dilemma? Storytelling

    Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.

    By May 5, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Profile

    From cancer survivor to clinical trial innovator

    How Alicia Staley is using her insights as a three-time cancer survivor to drive clinical trial improvements at Medidata.

    By Kelly Bilodeau • May 3, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    One company's failed drug is this company's 'jewel'

    Dr. Thomas Bock, CEO of Notable, is helping the company develop a ‘new class’ of predictive precision medicines in oncology.

    By May 2, 2022
  • Image attribution tooltip

    Permission granted by Laura Randa. 

    Profile

    Laura Randa's aim to break down mental healthcare barriers for disabled patients

    Despite the proliferation of mental health apps, many aren’t accessible for people with disabilities. The CEO of Toivoa plans to change that.

    By Alexandra Pecci • April 27, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Gilead Science's Dr. Shanthi Ganeshan

    As vice president of Global Regulatory Affairs, Oncology at Gilead, Ganeshan says there’s ‘never a dull moment’ in the quest to deliver therapies to patients.

    By April 27, 2022
  • Image attribution tooltip
    iStock via Getty Images
    Q&A

    Real-world data is making drug development more true to life

    How RWD is moving from the background to the spotlight in pharma’s development process.

    By Kelly Bilodeau • April 26, 2022
  • Image attribution tooltip

    Permission granted by Ted Love. 

    Profile

    For Global Blood Therapeutics, the connection to sickle cell disease runs deep

    An underserved patient population is a guiding light for the company, which recently scored a new approval.

    By Robin Robinson • April 19, 2022
  • Image attribution tooltip
    Justin Sullivan / Staff via Getty Images
    Q&A

    How pharma can up its social media game

    Health Union’s VP of community development, Sara Hayes, discusses how pharma marketers can better reach online patient communities. 

    By April 18, 2022
  • Image attribution tooltip
    MuseStudio/Shutterstock.com
    Sponsored by Avant Healthcare

    Clinical content that meets the top 3 needs of HCPs

    Learn how to meet the needs of HCPs with clinical content designed to be served up, save time, and satisfy curiosity.

    By Rob Spalding is the Chief Strategy & Marketing Officer at Avant Healthcare • April 18, 2022
  • Image attribution tooltip
    Permission granted by GoodRx
    Sponsored by GoodRx

    Inflation is forcing prioritization of healthcare spending — are you ready?

    Inflation means your customers' money doesn't travel as far as it did a few weeks ago.

    April 18, 2022
  • Image attribution tooltip
    Stock via Getty Images

    What now? Alzheimer's drugmakers ponder the path to approval

    Why Medicare’s unprecedented decision to limit coverage for Aduhelm could have a chilling effect on Alzheimer’s R&D.

    By Kelly Bilodeau • April 14, 2022
  • Image attribution tooltip
    iStock via Getty Images

    'Bootcamp' helps rare disease advocates learn the ropes of drug development

    Ultragenyx’s CEO on why supporting others in rare diseases pays dividends all around.

    By Kim Ribbink • April 12, 2022
  • Image attribution tooltip
    Kenny Holston via Getty Images

    Why the war in Ukraine could accelerate the deglobalization of clinical trials

    COVID slowed many studies — but the war could further strain clinical trials worldwide.

    By April 12, 2022
  • Image attribution tooltip
    Justin Sullivan via Getty Images

    Clinical trial recruitment hits the local pharmacy counter

    CVS Health's partnership with clinical trial software company Medable is designed to make recruitment easier for patients and drug makers alike.

    By Kelly Bilodeau • April 5, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Down but not out: How AVEO's CEO steered the company past an FDA rejection

    Michael Bailey explains why focusing on the patient helped AVEO clear regulatory hurdles to bring a new cancer drug across the finish line.

    By Kim Ribbink • April 5, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Time-saving tech lights Alcon's path into digital innovation

    Kevin Yapp, global head or omni-channel transformation at the Swiss eye health company shares why the customer should be a  North Star when developing digital tools.

    By Kim Ribbink • April 4, 2022
  • Image attribution tooltip

    Permission granted by Alloy.

    Profile

    From media to menopause: Creating new spaces in women's telehealth

    Why the former editor-in-chief of Marie Claire abandoned her magazine career to create a menopause-focused women's health startup.

    By Alexandra Pecci • March 29, 2022
  • Image attribution tooltip

    Permission granted by Steve Leber.

    How a rock 'n' roll guru is putting a new spin on health education for patients

    A former agent for The Rolling Stones has launched a healthcare streaming platform with a cast of entertainment heavyweights — and he wants pharma to be a headline act.

    By March 28, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Rare Patient Voice's president is striving to create a five-star experience for patients

    Successful clinical trial recruitment depends on listening to and empowering patients.

    By Kim Ribbink • March 23, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Merck's Dr. Mary-Ann Etiebet

    The associate VP of health equity is on a quest to address the relationship between health, gender and economic opportunities.

    By March 23, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Why Astellas is adopting a 'focus area approach' to partnerships

    Chief Strategy Officer, Naoki Okamura, explains why new trends and innovations require a different approach to alliances.

    By Kim Ribbink • March 22, 2022
  • Image attribution tooltip
    Retrieved from PharmaVOICE on March 21, 2022
    Q&A

    BioMarin's new global head of advocacy is tackling the holy grail of patient engagement

    In her new role, Dr. Roz is keeping her patient-first approach.

    By March 21, 2022
  • Image attribution tooltip
    Stock via Getty Images

    Attralus' medical officer believes systemic amyloidosis could be 'solvable'

    Gregory Bell is not just aiming to treat amyloidosis, but eventually cure it.

    By Robin Robinson • March 18, 2022
  • Image attribution tooltip
    Stock via Getty Images

    Civica Rx thinks it has a cure for high insulin prices

    Civica’s president and CEO, Martin VanTrieste, explains the nonprofit’s aim to manufacture low-cost insulin — and which area of pharma it plans to target next.

    By Kelly Bilodeau • March 16, 2022